Keeping therapeutics thermally stable results in high delivery costs. We aim to enable vaccines to survive without refrigeration and decrease these costs.
We are developing a thermal stabilization platform technology for temperature- sensitive vaccines and medicines, using a safe, low cost, and scalable polymer that is well understood. Nanoly's encapsulation and photo-release approach introduces minimal changes to administrative protocol for the vaccine or medicine. Our goal is to enable immunization access anywhere while simultaneously eliminating the refrigeration cost for lifesaving medicine.